These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 18474544)
1. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67. Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685 [TBL] [Abstract][Full Text] [Related]
3. mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma. Wang Y; Li Y; Zhang WY; Xia QJ; Li HG; Wang R; Yang L; Sun XF; Zhou ZG Eur J Cancer Prev; 2009 Feb; 18(1):40-5. PubMed ID: 19077563 [TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma. Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496 [TBL] [Abstract][Full Text] [Related]
5. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis]. Maruyama K; Saigusa N; Baba S; Kino I Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778 [TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
9. [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance]. Wang Y; Zhou ZG; Xia QJ; Zhang WY; Li HG; Wang R Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):465-8. PubMed ID: 18803052 [TBL] [Abstract][Full Text] [Related]
10. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells? Kimura F; Kawamura J; Watanabe J; Kamoshida S; Kawai K; Okayasu I; Kuwao S Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496 [TBL] [Abstract][Full Text] [Related]
11. [Expression of proliferation and apoptosis markers in neoplasms of colon mucosa after cholecystectomy]. Galitskiĭ MV; Khomeriki SG; Nikiforov PA Eksp Klin Gastroenterol; 2009; (5):28-32. PubMed ID: 20205327 [TBL] [Abstract][Full Text] [Related]
12. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications. Hashimoto K; Araki K; Osaki M; Nakamura H; Tomita K; Shimizu E; Ito H Pathobiology; 2004; 71(4):193-200. PubMed ID: 15263808 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647 [TBL] [Abstract][Full Text] [Related]
14. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis. Kuniyasu H; Oue N; Shigeishi H; Ito R; Kato Y; Yokozaki H; Yasui W J Exp Clin Cancer Res; 2001 Dec; 20(4):543-8. PubMed ID: 11876549 [TBL] [Abstract][Full Text] [Related]
16. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication. Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445 [TBL] [Abstract][Full Text] [Related]
17. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354 [TBL] [Abstract][Full Text] [Related]
18. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. McKay JA; Douglas JJ; Ross VG; Curran S; Loane JF; Ahmed FY; Cassidy J; McLeod HL; Murray GI J Pathol; 2002 Apr; 196(4):386-93. PubMed ID: 11920733 [TBL] [Abstract][Full Text] [Related]
19. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Cho Mar K; Eimoto T; Nagaya S; Tateyama H Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928 [TBL] [Abstract][Full Text] [Related]
20. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]